JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 41 No. 6 965-972
© 2000 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shigeyama, T.
Right arrow Articles by Ishikawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shigeyama, T.
Right arrow Articles by Ishikawa, K.

The Role of Exercise Radionuclide Angiocardiography in Predicting Future Cardiac Events in Patients with Acute Myocardial Infarction

Toshiki Shigeyama, Atsuo Yanagisawa and Kyozo Ishikawa

Second Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan

Correspondence: For correspondence or reprints contact: Kyozo Ishikawa, MD, Second Department of Internal Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan.

ABSTRACT

Left ventricular ejection fraction (LVEF) during exercise radionuclide angiocardiography is a useful prognostic index for patients with acute myocardial infarction (AMI). However, most previous studies were performed before reperfusion therapies (i.e., thrombolysis and coronary angioplasty) were widely used. Therefore, because reperfusion therapy has become a standard therapeutic option, we reexamined the prognostic value of rest LVEF and exercise LVEF determined by radionuclide angiocardiography in patients with AMI at the time of hospital discharge. Methods: The retrospective analysis included 419 consecutive patients with AMI who underwent ergometric stress radionuclide angiocardiography before hospital discharge, 44 ± 14 d after the onset of AMI. Results: During a mean follow-up of 4.6 y, cardiac events occurred in 101 (24.1%) patients. Cardiac events included recurrent Ml (33 patients, 7.9%), unstable angina (49 patients, 11.7%), congestive heart failure (16 patients, 3.8%), and ventricular tachycardia (3 patients, 0.7%). The LVEF at peak exercise was significantly lower in the group with cardiac events (P = 0.0140). However, no significant difference was observed in the rest LVEF between patients with and without cardiac events. On the basis of multivariate analysis using a Cox proportional hazards model, only peak LVEF (P = 0.0246) was found to be an independent predictor of cardiac events. In the patient subsets with a peak LVEF >50% or <50%, the event-free rate was 81.0% versus 62.4% (P = 0.0007), respectively. Regardless of the presence or absence of reperfusion therapy, the lower peak LVEF was associated with a decrease in the event-free survival rate. Conclusion: In the current reperfusion era, the lower peak LVEF as measured by radionuclide angiocardiography at the time of discharge is a useful predictor of subsequent cardiac events in patients with AMI.

Key Words: exercise radionuclide angiocardiography • prognosis • left ventricular ejection fraction • myocardial infarction







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2000 by the Society of Nuclear Medicine.